A tumultuous year for gene therapy

Mol Ther. 2000 Nov;2(5):415-6. doi: 10.1006/mthe.2000.0213.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adenoviridae / genetics
  • Adolescent
  • Clinical Trials as Topic / standards*
  • Genetic Therapy / standards*
  • Genetic Vectors / adverse effects
  • Humans
  • Male
  • National Institutes of Health (U.S.)
  • United States
  • United States Food and Drug Administration